NK function and clinical trastuzumab activity in metastatic breast cancer patients

被引:0
|
作者
Beano, A.
Signorino, E.
MA, Polimeni
Mistrangelo, M.
Spadi, R.
AM, Vandone
Donadio, M.
Matera, P.
Lista, I
Facilissimo, R.
Napolitano, L.
机构
[1] Osped San Giovana Battista, UOA Oncol Med, Turin, Italy
[2] Univ Turin, Dipartimento Med Interna, Lab Immunol Tumori, I-10124 Turin, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:38 / 38
页数:1
相关论文
共 50 条
  • [41] Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer
    Miller, KD
    Sisk, J
    Ansari, R
    Gize, G
    Nattam, S
    Pennington, K
    Monaco, F
    Sledge, GW
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 38 - 40
  • [42] Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function?
    Lu, Christine Y.
    Srasuebkul, Preeyaporn
    Drew, Anna K.
    Chen, Katie
    Ward, Robyn L.
    Pearson, Sallie-Anne
    BREAST, 2013, 22 (04): : 482 - 487
  • [44] Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study
    Extra, Jean-Marc
    Antoine, Eric C.
    Vincent-Salomon, Anne
    Delozier, Thierry
    Kerbrat, Pierre
    Bethune-Volters, Anne
    Guastalla, Jean-Paul
    Spielmann, Marc
    Mauriac, Louis
    Misset, Jean-Louis
    Serin, Daniel
    Campone, Mario
    Hebert, Christophe
    Remblier, Celine
    Bergougnoux, Loic
    Campana, Frank
    Namer, Moise
    ONCOLOGIST, 2010, 15 (08): : 799 - 809
  • [45] mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab
    Rapti, Vassiliki
    Moirogiorgou, Evangelia
    Koliou, Georgia-Angeliki
    Papadopoulou, Kyriaki
    Binas, Ioannis
    Pentheroudakis, George
    Bafaloukos, Dimitrios
    Bobos, Mattheos
    Chatzopoulos, Kyriakos
    Chrisafi, Sofia
    Christodoulou, Christos
    Nicolaou, Irene
    Sotiropoulou, Maria
    Magkou, Christina
    Koutras, Angelos
    Papakostas, Pavlos
    Kotsakis, Athanasios
    Razis, Evangelia
    Psyrri, Amanda
    Tryfonopoulos, Dimitrios
    Pectasides, Dimitrios
    Res, Eleni
    Alexopoulos, Athanasios
    Kotoula, Vassiliki
    Fountzilas, George
    ONCOLOGY LETTERS, 2022, 23 (01)
  • [46] Effect of Adjuvant/Neoadjuvant Trastuzumab on Clinical Outcomes in Patients With HER2-Positive Metastatic Breast Cancer
    Murthy, Rashmi K.
    Varma, Ankur
    Mishra, Priyankana
    Hess, Kenneth R.
    Young, Elliana
    Murray, James L.
    Koenig, Kimberly H.
    Moulder, Stacy L.
    Melhem-Bertrandt, Amal
    Giordano, Sharon H.
    Booser, Daniel
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    CANCER, 2014, 120 (13) : 1932 - 1938
  • [47] Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer
    Bruno, R
    Washington, CB
    Lu, JF
    Lieberman, G
    Banken, L
    Klein, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (04) : 361 - 369
  • [48] Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer
    Rene Bruno
    Carla B. Washington
    Jian-Feng Lu
    Grazyna Lieberman
    Ludger Banken
    Pamela Klein
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 361 - 369
  • [49] Management of Patients with Brain Metastases Receiving Trastuzumab Treatment for Metastatic Breast Cancer
    Witzela, Isabell
    Kantelhardt, Eva Johanna
    Milde-Langosch, Karin
    Ihnen, Maike
    Zeitz, Julia
    Harbeck, Nadia
    Jaenicke, Fritz
    Mueller, Volkmar
    ONKOLOGIE, 2011, 34 (06): : 304 - 308
  • [50] The acute effect of trastuzumab infusion on ECG parameters in metastatic breast cancer patients
    Yavas, Ozlem
    Yazici, Mehmet
    Eren, Onder
    Oyan, Basak
    SWISS MEDICAL WEEKLY, 2007, 137 (39-40) : 556 - 558